You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Short report
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program

 

Online download statistics by month:

Online download statistics by month: April 2020 to May 2026

AbstractFullPdf
Apr 2020616616211
May 2020305305122
Jun 202021421470
Jul 2020939348
Aug 2020828236
Sep 202015215271
Oct 202015215249
Nov 202014014244
Dec 202016616642
Jan 202115615638
Feb 202116816837
Mar 202120020066
Apr 202115315334
May 202111411462
Jun 2021989819
Jul 2021636322
Aug 2021828238
Sep 2021737333
Oct 2021777752
Nov 2021979741
Dec 2021828218
Jan 2022727824
Feb 2022373812
Mar 2022545719
Apr 2022586016
May 2022586022
Jun 2022798025
Jul 2022454514
Aug 2022575722
Sep 2022777825
Oct 2022586122
Nov 2022818311
Dec 2022585812
Jan 2023828415
Feb 2023949515
Mar 202374749
Apr 2023464611
May 2023727219
Jun 2023656611
Jul 2023777929
Aug 2023687220
Sep 2023757519
Oct 2023727212
Nov 202311811920
Dec 202311411414
Jan 2024404114
Feb 2024656513
Mar 2024747448
Apr 2024595921
May 2024434319
Jun 2024393912
Jul 2024787926
Aug 202440408
Sep 2024697114
Oct 2024424416
Nov 2024848518
Dec 202438397
Jan 2025515120
Feb 2025747410
Mar 2025606024
Apr 2025737321
May 2025404032
Jun 2025232312
Feb 2026110
May 2026330
Total597060121906